Elecsys®肌钙蛋白T Gen 5 STAT检测的分析性能评估
该研究评估了Elecsys®肌钙蛋白T Gen 5 STAT检测的分析性能,在锂肝素血浆样本中测定了测量限和范围,并按CLSI方案评价了精密度、交叉反应和干扰。结果显示在cobas e 411和e 601分析仪上重复性和中间精密度CV均较低,与骨骼肌肌钙蛋白T/I、心肌肌钙蛋白I及人肌钙蛋白C无交叉反应,生物素和34种药物无干扰。结论认为该检测在第99百分位参考上限处CV<10%,满足高敏肌钙蛋白检测的精密度要求。
要点
- 该检测在cobas e 411和e 601上重复性和中间精密度CV均<10%。
- 与骨骼肌肌钙蛋白T/I、心肌肌钙蛋白I及人肌钙蛋白C无交叉反应。
- 生物素(≤20 ng/mL)和34种药物未观察到干扰。
核心结论
- Elecsys® TnT Gen 5 STAT检测在第99百分位参考上限处CV<10%,满足高敏肌钙蛋白检测的精密度要求。
研究设计与样本
- 测量限和范围按CLSI EP17-A2在锂肝素血浆样本中测定。
- 精密度按CLSI EP05-A2使用锂肝素血浆/质控样本在cobas e 411和cobas e 601分析仪上评估,每天两批双份,连续21天(n=84)。
- 测试了与其他肌钙蛋白形式的交叉反应及内源性物质/药物的干扰。
主要发现
- cobas e 411上重复性/中间精密度CV为0.7-5.6%/1.4-10.3%(平均cTnT:7.3-9341 ng/L)。
- cobas e 601上重复性/中间精密度CV为0.7-3.0%/1.5-6.4%(平均cTnT:7.4-9455 ng/L)。
- 与骨骼肌肌钙蛋白T(≤10,000 ng/L)、骨骼肌肌钙蛋白I(≤100,000 ng/L)、心肌肌钙蛋白I(≤10,000 ng/L)或人肌钙蛋白C(≤80,000 ng/L)无交叉反应。
- 生物素(≤20 ng/mL)或34种药物未观察到干扰。
关键数值与推荐
- 无交叉反应的回收率标准为在±10%以内。
- 结论指出该检测在第99百分位参考上限处CV<10%,满足第四版心肌梗死全球定义对高敏肌钙蛋白检测的精密度要求。
临床怎么用
- 该检测的精密度和特异性性能支持其用于高敏肌钙蛋白检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We report the analytical performance of the Elecsys® Troponin T Gen 5 STAT (TnT Gen 5 STAT; Roche Diagnostics) assay. METHODS: Measuring limits/ranges were determined in lithium-heparin plasma samples per Clinical and Laboratory Standards Institute (CLSI) EP17-A2. Precision was evaluated per CLSI EP05-A2 using lithium-heparin plasma/quality control samples on cobas e 411/cobas e 601 analyzers; two duplicated runs per day for 21 days (n = 84). Cross-reactivity with other troponin forms and interference from endogenous substances/drugs was tested; recovery criterion for no cross-reactivity was within ±10%. RESULTS: Coefficients of variation (CV) for repeatability/intermediate precision were 0.7-5.6%/1.4-10.3% (cobas e 411; mean cardiac troponin T [cTnT]: 7.3-9341 ng/L) and 0.7-3.0%/1.5-6.4% (cobas e 601; mean cTnT: 7.4-9455 ng/L). There was no cross-reactivity with skeletal muscle troponin T (≤ 10,000 ng/L), skeletal muscle troponin I (≤ 100,000 ng/L), cardiac troponin I (≤ 10,000 ng/L), or human troponin C (≤ 80,000 ng/L). No interference was observed with biotin (≤ 20 ng/mL) or 34 drugs. CONCLUSION: The TnT Gen 5 STAT assay demonstrated a CV of <10% at the 99th percentile upper reference limit, meeting precision requirements (Fourth Universal Definition of Myocardial Infarction) for high-sensitivity troponin assays.
引用
- Fitzgerald RL, Hollander JE, Peacock WF, et al. Analytical performance evaluation of the Elecsys® Troponin T Gen 5 STAT assay. Clin Chim Acta. 2019. PMID: 31152695. doi:10.1016/j.cca.2019.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。